Robert E. Sell, Group Chief Exec-Com, Med & Technology at Accenture plc (ACN), sold 5,296 shares at $117.64 ($623K) on 2016-12-23, disclosed to the SEC on 2016-12-28.
Seasonal sale ($623k) by Group Chief Exec-Com, Med & Technology — this insider has traded ACN in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.64 | 2,648 | $312K | 50.0% |
| 2 | $117.64 | 2,648 | $312K | 50.0% |
| Total | $117.64 avg | 5,296 | $623K | 100% |
| Filing → |
| ACN | SELL | 2017-12-27 | $573K | — | Filing → |
| ACN | SELL | 2017-10-03 | $469K | — | Filing → |
| ACN | SELL | 2017-06-27 | $369K | — | Filing → |